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Received 19 May 2005; received in revised form 27 June 2005; accepted 30 June 2005AbstractThe inability of insulin to stimulate glucose metabolism in skeletal muscle fibres is a classic characteristic of type 2
diabetes. Using the non-obese Goto–Kakizaki rat as an established animal model of this type of diabetes, sucrose
gradient centrifugation studies were performed and confirmed the abnormal subcellular location of the glucose
transporter GLUT4. In addition, this analysis revealed an unexpected drastic reduction in the surface membrane
marker b-dystroglycan, a dystrophin-associated glycoprotein. Based on this finding, a comprehensive immunoblotting
survey was conducted which showed a dramatic decrease in the Dp427 isoform of dystrophin and the a/b-dystroglycan
subcomplex, but not in laminin, sarcoglycans, dystrobrevin, and excitation–contraction–relaxation cycle elements.
Thus, the backbone of the trans-sarcolemmal linkage between the extracellular matrix and the actin membrane
cytoskeleton might be structurally impaired in diabetic fibres. Immunohistochemical studies revealed that the
reduction in the dystrophin–dystroglycan complex does not induce obvious signs of muscle pathology, and is neither
universal in all fibres, nor fibre-type specific. Most importantly, the expression of a-syntrophin and the syntrophin-
associated neuronal isoform of nitric oxide synthase, nNOS, was demonstrated to be severely reduced in diabetic
fibres. The loss of the dystrophin–dystroglycan complex and the syntrophin–nNOS complex in selected fibres suggests
a weakening of the sarcolemma, abnormal signalling and probably a decreased cytoprotective mechanism in diabetes.
Impaired anchoring of the cortical actin cytoskeleton via dystrophin might interfere with the proper recruitment of the
glucose transporter to the surface membrane, following stimulation by insulin or muscle contraction. This may, at least
partially, be responsible for the insulin resistance in diabetic skeletal muscles.
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The inability of peripheral target tissues to properly
respond to insulin is a principal feature of type 2 diabetes
(Petersen and Shulman, 2002). Pathophysiological
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adipose tissue and muscle fibres (Moller, 2001). Since
skeletal muscles are responsible for up to 80% of whole
body insulin-stimulated glucose disposal, abnormal
hormone signalling in muscle fibres plays a central role
in insulin resistance (Boord et al., 2001). This signalling
defect affects millions of diabetic patients worldwide
(Zimmet et al., 2001) and has been estimated to rise even
further in developed countries (King et al., 1998).
Insulin-resistant type 2 diabetes represents an extremely
complex clinical disorder (Scheen, 2003) that is influ-
enced by both genetic factors (Almind et al., 2001) and
modern lifestyle (Sowers and Frohlich, 2004). Recent
studies with tissue-specific ablation of the insulin
receptor have revealed that both canonical insulin
targets, e.g. skeletal muscle and adipose tissue, and
non-canonical insulin targets, e.g. liver, pancreas and
brain tissues, may contribute in distinctly different ways
to clinical insulin resistance (Okamoto and Accili, 2003).
The insulin receptor represents a tyrosine kinase, where-
by insulin binding to the a-subunits causes the b-subunits
to autophosphorylate, thus activating the catalytic
activity of the receptor complex. The activated insulin
receptor phosphorylates a number of different intracel-
lular targets, e.g. insulin receptor substrate 1 (IRS1).
IRS1 serves as a docking molecule for the recruitment
and activation of other signalling elements with Src
homology 2 domains, such as the growth factor receptor-
bound element Grb2, that ultimately mediates control of
intermediary metabolism by insulin (Schmitz-Peiffer and
Whitehead, 2003). Subsequent steps in the insulin
receptor pathway include IRS1-associated phosphoino-
sitide-3-kinase activity, Akt kinase serine phosphoryla-
tion and glucose transporter activation. Thus,
recruitment of signalling molecules by the activated
insulin receptor is an extremely complex scenario and the
many steps and interactions with other surface protein
species have not yet been fully elucidated.
The rate-limiting step in skeletal muscle glucose
metabolism is represented by glucose transportation.
Within the glucose transporter family of proteins, the
insulin-sensitive type 4 glucose transporter, usually re-
ferred to as GLUT4, is the principal isoform in muscle
(Cushman et al., 1998). Previous studies have demon-
strated co-localization of GLUT4 vesicles with a dystro-
phin-rich membrane following insulin stimulation of
skeletal muscle fibres (Kahn et al., 1991). It was therefore
of interest to evaluate the status of members of the
dystrophin–glycoprotein complex in diabetic muscle fibres.
In addition, Grb2, an adapter protein involved in signal
transduction, was shown to directly interact with the
dystrophin-associated dystroglycans and syntrophins
(Yang et al., 1995; Oak et al., 2001). Glucose transport
is also stimulated by skeletal muscle contraction involving
nitric oxide and cGMP as signalling intermediates (Etgen
et al., 1997). This makes investigations into the role of thedifferent subtypes of nitric oxide synthase in skeletal
muscle a key issue for understanding the various pathways
that regulate GLUT4 translocation to the surface
membrane. The nitric oxide synthase isoform nNOS has
been shown to interact with dystrophin-associated proteins
(Grozdanovic and Baumgarten, 1999), warranting an
investigation of syntrophin-linked nNOS in diabetic
muscle fibres. Since primary or secondary abnormalities
in the dystrophin–glycoprotein complex are the underlying
cause of various neuromuscular diseases, including Duch-
enne muscular dystrophy, Becker’s muscular dystrophy,
congenital muscular dystrophy, and certain forms of limb-
girdle muscular dystrophy (Campbell, 1995; Ohlendieck,
1996), impaired muscle glucose metabolism and/or skeletal
muscle weakness observed in diabetic patients (Andersen
et al., 2004) could possibly be related to abnormal
expression levels of the dystrophin complex and its many
associated elements.
The non-obese Goto–Kakizaki (GK) rat model of type 2
diabetes was employed in this study. The spontaneously
diabetic GK rat represents a well-established animal disease
model (Kitahara et al., 1978), which demonstrates increased
blood glucose levels without alterations in body weight or
non-fasting plasma insulin level (Witte et al., 2002). It could
be argued therefore, that GK tissues are a suitable source
for the investigation of fundamental mechanisms of
diabetes, in the absence of complicating factors such as
obesity. Severe pathophysiological symptoms including
defects in insulin secretion and peripheral insulin resistance
usually occur by 4 weeks of age (Abdel-Halim et al., 1994;
Portha et al., 1991). GK skeletal muscles appear to exhibit a
reduced percentage of oxidative fibres (Yasuda et al., 2002)
and also show fibre type-specific defects, with IRS1 and
PI3K activity decreased primarily in oxidative muscles
(Song et al., 1999). Activities of insulin signalling inter-
mediates including PI3K, PKB/Akt and ERK were found
to be impaired in GK muscle (Steiler et al., 2003; Krook
et al., 1997). In addition, insulin receptor autophosphoryla-
tion and IRS1 tyrosine phosphorylation are inhibited in the
GK rat (Dadke et al., 2000), suggesting chronically
impaired signalling via the insulin pathway in skeletal
muscle of this animal model. Here, we can show that the
expression of the membrane cytoskeletal protein dystrophin
and some of its associated elements are affected in diabetic
GK skeletal muscle fibres. In analogy to muscular
dystrophies, this molecular defect may at least partially
explain impaired membrane signalling associated with the
diabetic phenotype.Materials and methods
Materials
Protogel acrylamide stock solutions were obtained from
National Diagnostics (Atlanta, GA, USA). Bradford
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Bio-Rad Laboratories (Hemel Hempstead, Herts, UK).
Immobilized pH gradient (IPG) strips of pH 3–10
and IPG buffer of pH 3–10 were obtained from
Amersham Biosciences (Little Chalfont, Bucks, UK).
Protran nitrocellulose membranes were from Schleicher
and Schuell (Dassel, Germany) and protease inhibitors
from Roche Diagnostics GmbH (Mannheim, Germany).
Primary antibodies were purchased from Affinity
Bioreagents, Golden, CO (mAb VIIID12 to fast
calsequestrin, mAb IIH11 to the fast SERCA1 isoform of
the sarcoplasmic reticulum Ca2+ ATPase, mAb IIID5
to the a1S-subunit of the dihydropyridine receptor,
mAb 34C to the ryanodine receptor and mAb 88B to
the d-subunit of the nicotinic acetylcholine receptor);
Upstate Biotechnology, Lake Placid, NY (mAb C464.6 to
the a1-subunit of the Na
+/K+-ATPase, mAb VIA41
to a-dystroglycan, mAb 3F2 to the growth factor
receptor-bound element Grb2, and pAb 06-528 to the
neuronal isoform nNOS of nitric oxide synthase);
Chemicon International, Temecula, CA (mAb MAB374
to glyceraldehyde-3-phosphate dehydrogenase, mAb
CT-3 to the b-subunit of the insulin receptor and mAb
8–63 to the IRS1); Novacastra Laboratories, Newcastle
upon Tyne, UK (mAb NCL43 to b-dystroglycan, mAb
NCL-DYS to dystrophin, and mAb NCL-aSARC to
a-sarcoglycan); Santa Cruz Biotechnology, Santa Cruz,
CA (pAb c-15 to d-sarcoglycan and pAb v-19 to
a-dystrobrevin); Abcam Ltd., Cambridgeshire, UK (pAb
Ab654 to the glucose transporter GLUT4); and
Sigma Chemical Company, Poole, Dorset, UK (pAb
AG-17 to a-syntrophin and pAb L9393 to laminin).
Affinity-purified and peroxidase-conjugated secondary
antibodies were obtained from Chemicon International.
Chemiluminescence (ECL) substrates and fluorescein- or
rhodamine-conjugated anti-mouse and anti-rabbit IgG
secondary antibodies were obtained from Pierce Bio-
technologies (Rockford, IL). All other chemicals used,
including those for MALDI-ToF mass spectrometry,
were of analytical grade and purchased from Sigma
Chemical Company.Animal model
Freshly dissected hind limb skeletal muscle specimens
from 12-week-old normal control Wistar rats and age-
matched GK diabetic rats (Kitahara et al., 1978) were
received from the Biomedical Facility of the National
University of Ireland, Dublin. Rats had been originally
purchased from M & B Taconic Ltd. Animal Suppliers
(Ry, Denmark). Rats were maintained on a 12-h light/
dark cycle, at a constant temperature of 22 1C, and food
and water were available ad libitum. For the validation
of individual GK rats as a suitable animal model of
human type 2 diabetes, non-fasting blood samples weretaken from the tail vein of 12-week-old rats for
measurement of glucose levels using the Accu Chek
Advantage II system from Roche GmbH (Mannheim,
Germany). Plasma insulin levels were determined in
sodium heparin blood tubes from BD Biosciences
(Nottingham, UK) employing a rat insulin ELISA test
from Mercodia (Stockholm, Sweden). Tests were
performed according to the manufacturer’s instructions.
GK rats (11.2470.51mM glucose; n ¼ 33) showed a
significant increase in glucose levels, as compared to age-
matched normal Wistar rats (6.5770.14mM glucose;
n ¼ 34). In contrast, insulin levels were relatively
comparable between both rat strains (GK rat:
0.3770.06 mmol/l insulin, n ¼ 33; Normal rat: 0.367
0.07 mmol/l insulin, n ¼ 31). The average body weight of
diabetic animals (245.873.4 g, n ¼ 34) was slightly
below that of normal rats (257.473.8 g, n ¼ 34).Preparation of crude microsomal membranes
Crude microsomal membranes were isolated from
normal and GK skeletal muscle homogenates by an
established subcellular fractionation method (Murray
and Ohlendieck, 1997). To avoid proteolytic degrada-
tion of muscle proteins, all procedures were carried out
at 4 1C in the presence of a protease inhibitor cocktail
(0.15 mM aprotinin, 1 mM leupeptin, 1.4 mM pepstatin,
0.5 mM soyabean trypsin inhibitor, 0.2mM pefabloc,
100 mM PMSF, and 1mM EDTA). Protein concentra-
tion was determined according to Bradford (1976) and
microsomal membrane vesicles were resuspended at a
final protein concentration of 10mg/ml. Isolated mem-
branes were used immediately for gel electrophoretic
separation.Gel electrophoresis and immunoblot analysis
Electrophoretic separation of microsomal proteins
was carried out under reducing conditions using
standard sodium dodecyl sulfate polyacrylamide gel
electrophoresis (Dunn and Bradd, 1993). Employing a
Mini-Protean MP3 electrophoresis system from Bio-
Rad Laboratories (Hemel Hempstead, Herts, UK), 7%
(w/v) resolving gels were used and 30 mg protein loaded
per lane. Electrophoretic transfer to nitrocellulose
membranes was conducted at 100V for 60min accord-
ing to Towbin et al. (1979). Incubation with antibodies
and visualization of immuno-decorated protein bands
was carried out by the enhanced ECL technique (Bradd
and Dunn, 1993). Densitometric scanning of developed
films was performed on an Epi Chemi II Geldoc UVP
Image Analysis System, with Labworks 4.0 Image
Acquisition & Analysis Software (BioImaging Systems,
Ultra Violet Products Ltd., Cambridge, UK). Statistical
analyses were performed using Graphpad Prism 4.01
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Student’s t-test was used to test for statistical signifi-
cance. Blot overlay analysis with peroxidase-conjugated
calsequestrin has been developed in our laboratory
(Glover et al., 2002) and was carried out as previously
described in detail (Mulvey and Ohlendieck, 2003).
Two-dimensional gel electrophoretic analysis of
crude muscle extracts
To confirm the results from one-dimensional immu-
noblotting of microsomal membranes, two-dimensional
immunoblotting with total skeletal muscle extracts was
additionally performed. The preparation of muscle
extracts for 2D gel electrophoresis has recently been
optimized by our laboratory and described in detail
(Dowling et al., 2004; Doran et al., 2004). Prior to
isoelectric focussing, 1 g of skeletal muscle was snap-
frozen in liquid nitrogen, ground to a fine powder,
subjected to acetone washes and precipitation, and then
solubilized in lysis buffer (9.5M urea, 0.5% (v/v)
ampholytes pH 3–10, 4% (w/v) CHAPS, 100mM
DTT). In order to prevent protein degradation, the
solution was supplemented with a protease inhibitor
cocktail, as described above. The samples were incu-
bated at room temperature for 3 h, centrifuged at
14,000g for 20min and then the supernatant diluted to
a final protein concentration of 100 mg per strip.
Isoelectric focussing was performed using an IPGphor
focussing system from Amersham Biosciences with 7-cm
or 13-cm linear IPG strips of pH 3–10. Following
isoelectric focussing, proteins were separated in the
second dimension by sodium dodecyl sulfate polyacryl-
amide gel electrophoresis (Froemming and Ohlen-
dieck, 2001).
Mass spectrometry-based proteomics analysis
In order to carry out a comparative proteomics
analysis of normal versus diabetic muscle fibres, the
silver-stained 2D spot pattern of total protein extracts
from normal versus diabetic muscle homogenates was
quantified by densitometric scanning (Doran et al.,
2004). Image analysis was performed with an Epi Chemi
II Geldoc UVP Image Analysis System using Labworks
4.0 Image Acquisition and Analysis Software package
(BioImaging System) for the evaluation of potential
expression changes in candidate protein spots. Three
separate control and three separate diabetic protein
complement preparations were used to determine the
fate of specific muscle protein species. As outlined
above, statistical analyses were carried out with Graph-
pad Prism 4.01 (Graphpad Software), whereby the
unpaired Student’s t-test was employed to test for
statistical significance. Gels were stored in 10% (v/v)acetic acid for further analysis by mass spectrometry.
2D protein spots were excised from the slab gel using 1-
ml pipette tips and then transferred to Eppendorf tubes
for destaining, chemical reduction and alkylation, as
previously described in detail (Doran et al., 2004). For
peptide fingerprinting of individual gel plugs, enzymatic
digestion was initiated by the addition of trypsin.
Following overnight digestion at 37 1C, tryptic frag-
ments were mixed with a preparation of a-cyano-4-
hydroxycinnamic acid and spotted onto the sample
plates for MALDI-ToF mass spectrometric analysis.
Angiotensin III (897.5m/z) and ACTH (2465.19m/z)
were employed as internal standards of known peptide
mass. An Amersham MALDI-ToF Pro instrument in
the positive reflector mode with an accelerating voltage
of 20 kV and pulsed extraction was used for the
recording of mass spectra, and Ettan MALDI Evalua-
tion Software Version 2 from Amersham Biosciences
was employed for mass spectra analysis. Protein
identification using the generated peptide mass finger-
print was then achieved with the PMF Pro-Found
search engine and the NR database. Predicted pI and
kDa values for each identified protein, as well as percent
sequence coverage by the digestion-generated peptides,
were provided by the software programme. All positive
protein hits generated by Amersham Biosciences
MALDI evaluation software were matched against the
publicly available search engine MASCOT (http://
www.matrixscience.com).Subcellular fractionation by sucrose gradient density
centrifugation
Subcellular muscle fractions were isolated by a
centrifugation method adapted from Garvey et al.
(1998). This method is a modification of that previously
used to demonstrate insulin-mediated translocation of
glucose transporters in rat muscle (Klip et al., 1987). All
preparative steps were conducted at 4 1C in the presence
of a protease inhibitor cocktail. Crude skeletal micro-
somal membranes (80mg protein) were carefully layered
on top of a discontinuous sucrose tri-layer of 25% (w/v),
28% (w/v) and 32% (w/v) sucrose solution containing
25mMHEPES (pH 7.5) and 1mM EGTA. The gradient
was centrifuged at 150,000g for 16 h in a swinging
bucket SW32 rotor at 4 1C using an Optima L-100 XP
Ultracentrifuge from Beckman Coulter (Palo Alto, CA,
USA) to achieve sufficient separation of subcellular
membrane fractions. Well-defined bands were visible at
the interfaces between each layer, with the 25% and
32% bands representing crude fractions derived from
the surface membranes and intracellular membranes,
respectively. Individual membrane fractions and the
pellet fraction were collected, washed by 5-fold dilution
in the above-mentioned HEPES buffer and then pelleted
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Beckman Ti70 rotor. The resulting subcellular fraction
pellets were resuspended in HEPES buffer and immedi-
ately used for electrophoretic separation and subsequent
immunoblot analysis.
Immunofluorescence microscopy and histochemical
staining
Tissue preparation, cryo-sectioning and antibody
incubation were performed as previously described in
detail (Culligan et al., 2002). Transverse sections of
12 mm thickness were prepared using a standard cryostat
from Microm (Heidelberg, Germany) and mounted on
Superfrost Plus positively charged microscope slides
(Menzel Gla¨ser, Braunschweig, Germany). Following
fixation and blocking, muscle sections were incubated
with primary and fluorescein- or rhodamine-conjugated
secondary antibodies. Fluorescent images were viewed
with an AxioCam HRc microscope from Carl Zeiss
Vision GmbH (Munich, Germany) and recorded with a
digital camera using Axiovision 4 image acquisition
software. Haematoxylin and eosin (H&E) staining of
tissue sections, labelling of nuclei with DAPI, and
histochemical staining for succinate dehydrogenase and
NADPH diaphorase were performed by standard
procedures (Kameya et al., 1999; Yasuda et al., 2002;
Dowling et al., 2004).N GK N GK
Fig. 1. Immunoblot analysis of the insulin receptor and
glucose transporter in GK skeletal muscle microsomes.
Coomassie-stained gel (A) and identical immunoblots (B–E)
labelled with antibodies to the insulin receptor (B; IR), the
insulin receptor substrate (C; IRS1); the growth factor
receptor-bound protein 2 (D, Grb2), and the glucose
transporter (E; GLUT4). (F–I) Graphical presentation of the
immunoblot analysis (n ¼ 15; no significant differences;
unpaired t-test). Lanes 1 and 2 represent membranes from
normal control muscle (N) and diabetic Goto–Kakizaki
muscle (GK), respectively. Molecular mass standards (in
kDa) are indicated on the left. The positions of immuno-
decorated proteins are marked by arrowheads.Results
Insulin resistance in skeletal muscle is an extremely
important feature of type 2 diabetes (Petersen and
Shulman, 2002). Here, we have used the non-obese GK
rat model to determine potential abnormalities in
diabetic skeletal muscle fibres. Following the initial
discovery that the expression of the sarcolemmal
glycoprotein b-dystroglycan is affected in GK skeletal
muscle, the biochemical and cell biological status of
important dystroglycan-associated proteins was deter-
mined.
Abnormal subcellular localization of glucose
transporter in diabetic GK skeletal muscle
As illustrated in the Coomassie-stained gel (Fig. 1A),
the overall protein composition of normal and GK
microsomes from skeletal muscle is relatively compar-
able. Immunoblotting with antibodies to the insulin
receptor, the IRS1, the growth factor receptor-bound
protein Grb2 and the muscle glucose transporter
isoform GLUT4 (Fig. 1B–E) revealed no statistically
significant differences in their expression levels between
control and diabetic specimens (Fig. 1F–I). Followingthis initial analysis of the abundance of key regulators of
glucose metabolism, the subcellular location of the main
muscle glucose transporter was determined by sucrose
gradient centrifugation. For standardization, the dis-
tribution of markers of the sarcolemma, the transverse
tubules and the sarcoplasmic reticulum in the various
fractions were determined. The surface Na+/K+-ATP-
ase was mostly found in the lightest membrane fraction
at the top of the sucrose density gradient (Fig. 2A), the
a1S-subunit of the dihydropyridine receptor was en-
riched in the 25% to 32% sucrose fractions (Fig. 2B)
and the terminal cisternae component calsequestrin was
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abundant sarcoplasmic reticulum membranes appear to
cross-contaminate lighter fractions, the immuno-decora-
tion of marker proteins demonstrated an overall
successful fractionation between lighter and heavier
membrane fractions. In contrast to normal muscle,
which showed an association of the GLUT4 isoformNormal GK
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Fig. 2. Subcellular fractionation analysis of glucose trans-
porter GLUT4 in GK skeletal muscle. Identical immunoblots
labelled with antibodies to the a1-subunit of the Na
+/K+-
ATPase (A), the a1S-subunit of the dihydropyridine receptor
(B; DHP), calsequestrin (C; CSQ), the glucose transporter (D;
GLUT4), and b-dystroglycan (E). Lanes 1–4 and lanes 5–8
represent membranes from normal control muscle and diabetic
Goto–Kakizaki muscle (GK), respectively. Fractions were
prepared by sucrose density gradient centrifugation and
correlate to a 25%, 28% and 32% (w/v) sucrose concentration
and the pellet (P).with lighter membrane fractions representing surface
and internal membranes, the glucose transporter was
found in GK muscle in a heavier membrane fraction
(Fig. 2D). This finding indicates an abnormal location
of GLUT4 in basal, non-insulin-stimulated diabetic GK
muscle. However, the most interesting result taken from
this immunoblot analysis was the observation that the
expression of another surface membrane marker, the 43-
kDa sarcolemmal glycoprotein named b-dystroglycan,
was drastically reduced (Fig. 2E). Since dystroglycans
form an important complex that indirectly links the
cortical cytoskeleton to the extracellular matrix, we
initiated a comprehensive immunoblotting survey of
dystroglycan-associated muscle components.
Reduced expression of the dystrophin–dystroglycan
complex in diabetic GK skeletal muscle
The central elements of the surface membrane that
associate with b-dystroglycan are the membrane cyto-
skeletal protein dystrophin of 427 kDa on the cytoplas-
mic side and a-dystroglycan of 156 kDa on the extra-
cellular side. Both muscle proteins interact with a range
of other surface elements, such as laminin, sarcoglycans,
dystrobrevins and syntrophins. Immunodecoration of
nitrocellulose replicas of gels with equally loaded lanes
(Fig. 3A) showed a drastic reduction in the expression of
the full-length dystrophin isoform Dp427 (Fig. 3C) and
both dystroglycans (Fig. 3D, E). In contrast, the a-
dystroglycan binding partner laminin (Fig. 3B) and the
dystrophin-associated proteins a-sarcoglycan, d-sarco-
glycan and a-dystrobrevin (Fig. 3F–H) were shown not
to be affected in the GK muscle. For control purposes,
the immunoblotting of the surface membrane marker
Na+/K+-ATPase is shown in Fig. 3I. The statistical
analysis of our immunoblotting survey is illustrated in
the bar diagrams of Fig. 3J–Q demonstrating the
significant reduction of dystrophin and a/b-dystrogly-
cans in diabetic muscle.
Reduction in the syntrophin-associated neuronal
isoform of nitric oxide synthase in diabetic GK
skeletal muscle
An important signalling enzyme that is associated with
the muscle dystrophin–glycoprotein complex via syntrophin
is the neuronal nitric oxide synthase isoform nNOS.
Interestingly, both the expression of a-syntrophin and
nNOS was found to be considerably less in diabetic GK
preparations as compared to control muscle (Fig. 4A, B, D,
E). In contrast, immunoblotting with an antibody to the
protein product of the house-keeping gene that encodes the
glyceraldehyde-3-phosphate dehydrogenase, showed a very
comparable level of this marker (Fig. 4C, F). The reduction
in nNOS was confirmed by a standard histochemical
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Fig. 3. Immunoblot analysis of dystrophin-associated glycoproteins in GK skeletal muscle. Coomassie-stained gel (A) and identical
immunoblots (B–I) labelled with antibodies to laminin (B; LAM), the full-length dystrophin isoform of 427 kDa (C; Dp427), a-
dystroglycan (D; a-DG), b-dystroglycan (E; b-DG), a-sarcoglycan (F; a-SG), d-sarcoglycan (G; d-SG), a-dystrobrevin (H; a-DYB),
and the a1-subunit of the Na
+/K+-ATPase (I; NKA). (J–Q) Graphical presentation of the immunoblot analysis (n ¼ 15; po0:01;
po0:001; unpaired t-test). Lanes 1 and 2 represent membranes from normal control muscle (N) and diabetic Goto–Kakizaki
muscle (GK), respectively. Molecular mass standards (in kDa) are indicated on the left. The positions of immuno-decorated proteins
are marked by arrowheads.
C. Mulvey et al. / European Journal of Cell Biology 84 (2005) 867–883 873analysis of transverse muscle sections. The staining pattern
showed nitric oxide synthases to be down-regulated in
diabetic tissue (Fig. 4G, H). Although this crude histo-
chemical staining procedure does not differentiate between
different NOS isoforms, it gives a good indication that the
expression levels of this group of enzymes are affected in
diabetes. Obviously, the result from immunoblotting is a
more reliable indicator with respect to isoform-specific
changes in NOS expression levels.Status of excitation–contraction coupling and muscle
relaxation elements in diabetic GK skeletal muscle
Since abnormal Ca2+ handling and impaired regula-
tion of the excitation–contraction–relaxation cycle isimplicated in secondary changes leading to skeletal
muscle fibre degeneration, we have investigated the
status of key ion-regulatory elements in diabetic fibres.
The main protein species involved in the regulation of
neuronal transmission, voltage sensing, Ca2+ release,
Ca2+ binding, endogenous receptor modulation and
Ca2+ uptake are represented by the nicotinic acetylcho-
line receptor of the post-synaptic muscle surface
membrane, the a1S-dihydropyridine receptor of the
transverse tubules, the ryanodine receptor Ca2+ release
channel complex of the triad junctions, calsequestrin
and calsequestrin-like proteins of the terminal cisternae
region and the SERCA-type Ca2+-ATPases. In analogy
to the comparable expression levels of major protein
species in normal versus diabetic fibres (Fig. 5A), no
major changes in the abundance of these six central
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cle relaxation were observed (Fig. 5B–F, H–M). Reduc-
tion in the expression of calsequestrin-like proteins is an
established feature of dystrophin-deficient muscle fibres,
such as the MDX animal model of Duchenne muscular
dystrophy (Culligan et al., 2002). The comparative
immuno-decoration of GK versus MDX microsomes
with monoclonal antibody VIIID12 to calsequestrin
clearly established the preserved status of these luminal
Ca2+-binding proteins in diabetic fibres (Fig. 5F, L, M),
but their drastic reduction in MDX preparations
(Fig. 5G, N, O). It has previously been shown that
muscle degeneration has an effect on protein–protein
interactions within the triadic membrane assembly
(Glover et al., 2002). In order to determine potential
differences between normal and diabetic muscle fibres,
we performed a blot overlay assay with a peroxidase-
conjugated calsequestrin probe. Using electrophoreti-
cally separated normal and GK preparations (Fig. 5P),
the calsequestrin probe was found to bind to itself, theryanodine receptor, calsequestrin-like proteins and
junctin (Fig. 5R). This binding pattern agreed with our
previous overlay analysis and showed no differences in
the protein–protein interaction between excitation–con-
traction elements in normal versus GK fibres. The
immunoblot of Fig. 5Q shows the relative position of
the calsequestrin monomer of apparent 63 kDa and the
CLPs of higher molecular mass. Thus, although the
expression of the dystrophin–dystroglycan complex is
reduced in GK muscle, this destabilising effect on the
sarcolemma does not appear to have a direct effect on
the expression levels and oligomeric status of ion-
regulatory components.Mass spectrometry-based proteomics analysis of
normal versus diabetic GK skeletal muscle
In order to determine whether the diabetic GK
phenotype is associated with major changes in the
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Fig. 5. Immunoblot analysis of excitation–contraction–relaxation cycle elements in GK muscle. Coomassie-stained gels (A, P) and
immunoblots (B–G; Q) labelled with antibodies to the d-subunit of the nicotinic acetylcholine receptor (B; d-nAChR), the a1S-
subunit of the dihydropyridine receptor (C; a1S-DHPR), the ryanodine receptor Ca
2+-release channel (D; RyR1), the fast isoform of
the sarcoplasmic reticulum Ca2+ ATPase (E; SERCA1), calsequestrin (F, G, Q; CSQ) and calsequestrin-like proteins (F, G, Q;
CLPs). A calsequestrin blot overlay is shown in (R). (H–O) Graphical presentation of the immunoblot analysis (n ¼ 15; po0:05;
unpaired t-test). Lanes 1 and 2 represent membranes from normal control muscle (N) and diabetic Goto–Kakizaki muscle (GK),
respectively. For comparative purposes, lanes 3 and 4 in (G) show membranes from control and dystrophic MDX muscle.
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densitometric scans of the electrophoretically-separated
normal versus GK protein complement were evaluated
with 2D analysis software. As outlined in a previous
proteomics survey of dystrophic skeletal muscle, two-
dimensional gel electrophoresis methodology is ham-
pered by a range of technical problems (Doran et al.,
2004). Limitations of protein staining, incomplete
transfers and the combination of isoelectric focussing
and standard polyacrylamide gel electrophoresis may
cause an under-representation of certain protein species,
such as low-abundance proteins, highly acidic or basic
proteins, integral membrane proteins and very high-
molecular-mass proteins. Therefore, the 2D spot pattern
shown in Fig. 6A, B is not representative of the complete
protein repertoire of normal and diabetic skeletal
muscle. However, despite these technical problems,
two-dimensional gel electrophoresis is still an unpar-
alleled technique for the proper separation of a wide
range of proteins with varying isolectric point and
molecular mass. The 2D gels shown here have separated
a broad range of high-abundance muscle components
including the contractile apparatus and various key
enzyme systems. The numbering of major protein spots
in the silver-stained gels highlights established muscle
marker proteins, which could be identified by mass
spectrometry (Fig. 6A, B). Spots 1–11 were identified by
mass spectrometric analysis as enolase-3b, aldolase-A,
tropomyosin-2b, creatine kinase, GAPDH-like protein,
tropomyosin-1a, thymidine kinase, myosin light chain-1,
adenylate kinase-1, myosin light chain-2, and parvalbu-
min, respectively. See Table 1 for results from the mass
spectra analysis of identified muscle proteins. The
densitometric analysis of the 11 proteins did not reveal
a statistically significant difference in their expression
levels between control and GK specimens. Importantly,
since adenylate kinase was recently shown to be greatly
reduced in dystrophin-deficient MDX preparations (Ge
et al., 2003), the persistent expression of this metabolic
enzyme indicates a lack of dystrophic pathology in GK
muscle. Overall, the proteomics screening of the GK
protein complement showed no major differences in the
protein expression profile as compared to normal
muscle.Two-dimensional gel electrophoretic analysis of
dystrophin-associated glycoproteins in diabetic GK
skeletal muscle
Differential centrifugation of tissue homogenates may
introduce artefacts during subcellular fractionation
steps that can potentially lead to the overestimation or
underestimation of the density of protein species with
respect to the total muscle protein complement. We have
therefore also employed comparative 2D immunoblot-ting of total crude muscle extracts. However, many
antibodies are not specific enough to properly recognize
low abundance epitopes in crude muscle preparations.
In addition, large proteins, such as dystrophin (427 kDa)
or the ryanodine receptor (565 kDa) do not properly
transfer from the isoelectric focussing strips into the
second slab gel dimension and can therefore not be
analysed by this technique. Nevertheless, a subset of
antibodies was able to detect specific proteins following
2D separation and confirmed the results from the 1D
analysis of microsomes. The silver-stained gels of Fig.
6A, B, used for mass spectrometric analyses as described
above, illustrate the relatively comparable overall
protein expression pattern of normal versus diabetic
GK muscle fibres. A more detailed proteomics ap-
proach, using the novel fluorescence difference gel
electrophoresis technique, suggests itself for identifying
potential minor changes in the protein expression profile
by mass spectrometry and will be attempted in future
studies. 2D immunoblotting revealed no major differ-
ences in the expression of the fast SERCA1 isoform of
the sarcoplasmic reticulum Ca2+-ATPase, glyceralde-
hyde-3-phosphate dehydrogenase, the insulin receptor,
the IRS1 and the adaptor molecule Grb2 between
normal and diabetic extracts (Fig. 6C–H). In contrast,
the abundance of the dystrophin-associated proteins a-
dystroglycan, b-dystroglycan, a-syntrophin and the
enzyme nNOS were found to be reduced in total GK
muscle preparations as compared to unaffected control
tissue (Fig. 6I–L). This agrees with 1D immunoblot
analyses in Figs. 1, 3, 4 and 5. The immunoblotting
image shown in Fig. 6D shows the entire 2D blot region
and illustrates the lack of low-molecular-mass fragments
of the 110 kDa Ca2+ pump. In agreement with the
preserved protein expression pattern of the GK protein
complement, as shown above by mass spectrometry-
based proteomics, this finding also suggests a lack of
major skeletal muscle pathology in the GK rat model of
type 2 diabetes.Drastic reduction of dystrophin and a/b-
dystroglycans in diabetic GK skeletal muscle fibres
as revealed by immunofluorescence microscopy
Indirect immunofluorescence microscopy was em-
ployed to study the effect of diabetes on the localization
of dystrophin and dystroglycans in skeletal muscle
fibres. Transverse cryosections, the cellular structure of
which was preserved as shown in the eosin-stained
panels of Fig. 7A, B, were immuno-decorated with
monoclonal antibodies to the proteins that constitute
the backbone of the dystrophin–glycoprotein complex.
Surface labelling for dystrophin, a-dystroglycan and b-
dystroglycan revealed a greatly reduced expression in
the majority of diabetic cells (Fig. 7C–H). While normal
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Table 1. Representative protein species identified in normal and diabetic skeletal muscle extracts by mass spectrometry-based
proteomics
Spot No. Protein Sequence coverage (%) Molecular mass (kDa) Isoelectric point pI SwissProt Acc. No.
1 Enolase 3b 41.9 47.35 6.7 P21550
2 Aldolase A 28.8 39.79 8.8 P05064
3 Tropomyosin 2b 25.7 32.93 4.7 P07951
4 Creatine kinase 36.5 43.23 6.6 P07310
5 GAPDH-like protein 19.2 36.05 8.7 P16858
6 Tropomyosin 1a 50.0 32.75 4.7 P58771
7 Thymidine kinase 25.1 28.99 9.5 P27158
8 Myosin light chain 1 73.5 20.78 5.0 P05977
9 Adenylate kinase 1 29.9 21.68 7.8 P39069
10 Myosin light chain 2 60.0 19.12 4.8 P97457
11 Parvalbumin 30.3 11.78 5.0 P32848
All positive protein hits generated by Ettan MALDI Evaluation Software Version 2 (Amersham Biosciences) were matched against the publicly
available search engine MASCOT (http://www.matrixscience.com). The densitometric analysis of the listed protein spots from 2D gels representing
normal muscle versus diabetic muscle did not reveal a statistically significant difference in expression levels between control and GK specimens.
C. Mulvey et al. / European Journal of Cell Biology 84 (2005) 867–883878muscle fibres exhibited a relatively even distribution of
the members of the dystrophin–dystroglycan complex in
the cellular periphery of most fibres, GK muscle sections
showed a clear lack of these sarcolemmal proteins in
selected fibres. To investigate a potential correlation
between fibre type distribution and absence of dystro-phin in GK tissue, Fig. 7I, J, illustrates the labelling of
serial sections. Since the SERCA1 isoform of the
sarcoplasmic reticulum Ca2+-ATPase exclusively labels
fast-twitch fibres, it can be employed as a reliable cell
biological marker of fast versus slow fibres (Fig. 7I). The
direct comparison between the localization of SERCA1
ARTICLE IN PRESS
Normal GK
A B
C
E
G
I
K
Normal GK
SDH
H&E
DAPI
NKA
LAM
CSQ
D
F
H
J
L
C. Mulvey et al. / European Journal of Cell Biology 84 (2005) 867–883 879and the patchy fibre staining pattern for the full-length
dystrophin isoform Dp427 showed no apparent rela-
tionship between fibre type and the abnormal protein
expression pattern. Abnormal dystrophin levels were
found in both fast and slow fibres (Fig. 7J).
Preserved histochemical and immunofluorescence
labelling of muscle markers indicates a lack of
general fibre degeneration in the GK rat model of
type 2 diabetes
In order to determine potential fibre degeneration
in GK muscle due to the reduction of the dystrophin–
dystroglycan complex, transverse cryosections were
labelled for the presence and distribution of marker
proteins using standard histochemical and immuno-
fluorescence techniques. The serial sections of normal
versus diabetic fibres in Fig. 8A–F show a relatively
normal distribution of the mitochondrial marker succi-
nate dehydrogenase and almost exclusively peripheral
nucleation in myofibres. Haematoxylin and DAPI
labelling revealed very little central positioning of nuclei,
which is frequently observed in dystrophic muscle fibres.
Thus, in contrast to the completely dystrophin-deficient
MDX model of Duchenne muscular dystrophy, GK
muscle with a partial reduction in the Dp427 isoform,
does not appear to exhibit a dystrophic phenotype. The
comparable immunofluorescence labelling patterns of
the surface marker Na+/K+-ATPase, the extracellular
matrix component laminin and the sarcoplasmic reticu-
lum protein calsequestrin (Fig. 8G–L) are in agreement
with this assessment. These findings confirm the
immunoblot analysis of this study and showed no
marked difference in the localization pattern of these
key muscle proteins. Hence, no major structural
abnormalities seem to exist in diabetic GK fibres.Fig. 8. Histochemical and immunofluorescence survey of GK
skeletal muscle. In order to evaluate whether diabetic GK
fibres show obvious signs of muscle pathology, transversely cut
cryosections were stained with standard histological, histo-
chemical and immunofluorescence techniques. Tissue sections
labelled for succinate dehydrogenase activity (A, B; SDH),
stained with haematoxylin and eosin (C, D; H&E), DAPI (E,
F; DAPI), and labelled with antibodies to markers of the
surface membrane (G, H; Na+/K+-ATPase, NKA), the
extracellular matrix (I, J; laminin, LAM), and the sarcoplasmic
reticulum (K, L; calsequestrin, CSQ). Bars ¼ 40mm (A–F),
20 mm (G–L). Cellular abnormalities that are commonly
observed in dystrophic fibres such as necrosis, large variations
in the size of myofibres, fibrosis, rounded contours of fibres,
infiltration of immune cells and central nucleation, do not
appear to be present in diabetic GK skeletal muscle.Discussion
Major efforts are underway to define the molecular
mechanisms that regulate glucose metabolism in insulin-
sensitive cells. Skeletal muscle is a key tissue responsible
for insulin-stimulated glucose disposal and thus the
major site of peripheral insulin resistance in type 2
diabetes (Baron et al., 1991). Impaired glucose transport
in skeletal muscle leads to impaired whole body glucose
uptake (DeFronzo, 1992). A combination of genetic and
environmental factors is likely to contribute to the
pathogenesis of this metabolic disorder (Moller, 2001).
Our initial investigation into the subcellular location of
the glucose transporter GLUT4 in basal, non-insulin
stimulated muscle agrees with previous studies (Garvey
et al., 1998) and suggests an abnormal accumulation of
GLUT4 vesicles in a dense membrane region, from
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recruit the transporter molecule. Although expression
levels of the insulin receptor, GLUT4 and associated
signalling molecules are not affected in GK muscles,
insulin resistance may result from the inability of a
critical amount of GLUT4 units to reach the plasma-
lemma. Since the fusion of GLUT4 with the muscle
surface membrane is essential for physiological glucose
uptake, a regulatory defect in the rate-limiting process
of GLUT4 trafficking and translocation is probably
central to diabetic pathology. In this respect, the results
presented in this report support the idea of a pathophy-
siological GLUT4 mechanism that may be involved in
abnormal signalling in diabetic skeletal muscle.
The finding that the sarcolemmal marker b-dystro-
glycan is reduced in GK muscle preparations led to an
in-depth investigation of the fate of the dystrophin–gly-
coprotein complex in diabetic skeletal muscle fibres. GK
muscles clearly exhibit a drastic reduction in the
membrane cytoskeletal component dystrophin and the
two core dystroglycan proteins that form the linkage
between the extracellular matrix protein laminin and
cortical actin in normal muscle. The abnormal expres-
sion pattern does not appear to correlate with the fast
versus the slow fibre type. Since the disintegration of the
dystrophin complex is the primary abnormality leading
to fibre weakness in many common muscle diseases
(Cohn and Campbell, 2000), we postulate that the
disturbances within the surface dystrophin–glycoprotein
complex may contribute to insulin resistance and
abnormalities characteristic of diabetic GK skeletal
muscle. We initiated this analysis because type 2
diabetes is associated with skeletal muscle weakness
(Andersen et al., 2004). Originally we expected a slight
disturbance of the surface membrane in diabetic fibres
linked to insulin resistance, but were surprised when we
discovered a dramatic reduction in dystrophin and some
of its associated glycoproteins, both by immunoblotting
and immunofluorescence microscopy.
The selective reduction in dystroglycans is probably
due to the fact that the a/b-dystroglycan subcomplex,
which forms the trans-sarcolemmal backbone of the
dystrophin–glycoprotein complex, is directly linked to
the Dp427 isoform, but sarcoglycans and laminin are
indirectly associated with dystrophin. However, due to
the lack of the complete pathophysiological scenario in
diabetic muscle, from our initial analysis of the GK rat
model, it is difficult to deduce the mechanism underlying
the loss of the dystrophin–dystroglycan complex in
selected diabetic myofibres. At this stage it is not
possible to link these downstream events to one or
more primary defects in type 2 diabetes (Almind et al.,
2001). Since dystrophin forms an integral part of a
multi-functional surface complex, various scenarios are
possible. The dystrophin-containing supramolecular
membrane assembly is involved in sarcolemmal stabili-zation during excitation–contraction–relaxation cycles,
signal transduction and receptor anchoring to the
cellular periphery (Culligan et al., 1998). Thus the
abnormal expression or reduced affinity of any binding
partner within this complex membrane arrangement
may have an indirect effect on dystrophin, which in turn
has an influence on the dystroglycans and associated
elements. Interestingly, the expression of the dystrophin-
linked signalling element syntrophin and its associated
enzyme nNOS (Grozdanovic and Baumgarten, 1999) is
severely affected in GK fibres.
Nitric oxide, a readily diffusible and short-lived agent,
is formed intracellularly by the action of NOS enzymes
and interacts with an array of molecular targets in- and
outside the cell. In skeletal muscle, nitric oxide mediates
diverse functions related to fibre development, metabo-
lism, contraction and blood flow (Lee et al., 1994;
Kobzik et al., 1994; Roberts et al., 1997). Loss of nNOS
may also result in aberrant regulation of adrenergic
vasoconstriction (Thomas et al., 1998). In addition,
nitric oxide represents an anti-inflammatory and cyto-
protective factor (Wehling et al., 2001) suggesting that a
reduction in nNOS may trigger muscle pathology
(Rando, 2001). This has been shown to be the case in
sarcoglycan-deficient muscles from patients afflicted
with limb-girdle muscular dystrophy (Crosbie et al.,
2002). In agreement with a reduced nNOS expression in
GK muscle is the recent report by Kashyap et al. (2005)
describing impaired nitric oxide synthase activity in
skeletal muscle from type 2 diabetic patients. Thus, if the
dystrophin–dystroglycan complex is reduced in diabetic
fibres, this may lead directly to a structural weakening of
the muscle fibre periphery and indirectly to abnormal
signal transduction due to the loss of important
enzymes, such as nNOS.
In various forms of muscular dystrophy, the disin-
tegration of the dystrophin–glycoprotein complex inter-
rupts the trans-plasmalemmal linkage between the actin
membrane cytoskeleton and the extracellular matrix
element laminin (Ohlendieck, 1996; Culligan et al.,
1998). The complete absence of the full-length Dp427
isoform of dystrophin renders muscle fibres more
susceptible to necrosis (Campbell, 1995; Cohn and
Campbell, 2000). The investigation of the fate of the
dystrophin–dystroglycan complex in insulin-resistant
tissue specimens, as reported here, suggests that a
partial reduction in these surface proteins does not
trigger general muscle degeneration. This assumption is
based on the fact that GK muscle exhibits a persistent
expression of calsequestrin-like proteins and adenylate
kinase, muscle components that are greatly reduced in
the MDX model of muscular dystrophy (Culligan et al.,
2002; Ge et al., 2003). Creatine kinase and adenylate
kinase provide a major nucleotide pathway, and the lack
of adenylate kinase suggests an abnormal regulation of
nucleotide ratios in MDX fibres (Ge et al., 2003). GK
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Mass spectrometry-based proteomics revealed no statis-
tically significant difference in the expression of major
contractile proteins and enzymes in normal versus
diabetic fibres demonstrating the lack of major protein
degradation. This is in agreement with the finding that
no low-molecular-mass fragments of the SERCA1
enzyme were found in GK preparations. The partial
loss of dystrophin does not appear to trigger extensive
proteolysis. Histochemical and immunofluorescence
analyses confirmed the lack of a dystrophic GK
phenotype, since most diabetic fibres do not show the
typical signs of muscular dystrophy such as central
nucleation, a large variation in fibre size, necrosis,
fibrosis, infiltration of immune cells or rounded con-
tours of myofibres (Ohlendieck and Campbell, 1991).
The preserved expression levels and subcellular
locations of muscle markers of the sarcolemma,
sarcoplasmic reticulum, extracellular matrix and mito-
chondria in diabetic fibres, which agree with previous
cell biological studies of GK muscle (Yasuda et al.,
2002), also demonstrate a lack of major muscle
pathology due to abnormal dystrophin expression in
these types of muscle. In severe forms of muscular
dystrophy, the primary or secondary complete defi-
ciency in dystrophin leads to a common pathological
pathway that eventually triggers muscle degeneration
(Culligan et al., 1998). In diabetes, the partial reduction
in dystrophin appears to trigger a considerably milder
phenotype. However, on the molecular level the reduced
expression of dystrophin and some of its associated
elements might cause impaired signalling and thus may
play a pathophysiological role in some metabolic
pathways. Many researchers in the field of muscular
dystrophy have accepted that abnormal Ca2+ fluxes
play a major part in muscle cell destruction (Alderton
and Steinhardt, 2000; Ohlendieck, 2005). Since dystro-
phin is reduced in diabetic muscle, the ion-regulatory
apparatus might also be affected in type 2 diabetes. We
could previously show that in a drug-induced animal
model of type 1 diabetes the Ca2+-binding element
calsequestrin is drastically up-regulated, probably com-
pensating for abnormal accumulations of elevated
intracellular Ca2+ levels in diabetic muscle fibres
(Howarth et al., 2002). However, screening of diabetic
GK muscle samples with a library of monoclonal
antibodies to key ion-handling proteins did not detect
abnormal expression levels in signalling elements that
might be indirectly linked to insulin resistance. Thus, the
loss of nNOS might represent the most important
pathophysiological consequence of the reduced dystro-
phin levels in GK fibres.
In conclusion, the analysis of the dystrophin–dystro-
glycan complex in GK skeletal muscle demonstrated a
loss of key membrane cytoskeletal elements in diabetic
fibres. This suggests a weakened muscle surface mem-brane in selected fibres and may cause in the long term
an enhanced rate of micro-rupturing during excitation–
contraction–relaxation cycles. The reduced expression
of syntrophin and nNOS may aggravate the diabetic
condition due to abnormal signalling and decreased
cytoprotective mechanisms. The disturbance of the
dystrophin complex may affect the integrity of the
cortical actin cytoskeleton and its linkage to the
sarcolemma. This may interfere with the ability of
GLUT4 proteins to correctly fuse with the surface
membrane and thereby inhibit glucose uptake. Conse-
quently, abnormal expression of dystrophin, dystrogly-
cans and syntrophin may exacerbate the insulin
resistance characteristic of non-obese, type 2 diabetic
skeletal muscle fibres. In seeking to develop new
therapeutic strategies, the rescue of dystrophin-asso-
ciated proteins may play a key role in preventing the
abnormal diabetic phenotype.Acknowledgments
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